The Intersection of Psychedelics and Sleep: Exploring the Impacts on Sleep Architecture, Dream States, and Therapeutic Implications
ACS Pharmacology & Translational Science – May 15, 2025
Source: OpenAlex
Summary
Psilocybin, LSD, and DMT profoundly alter **sleep architecture**, impacting **dream** recall. One investigation with 75 participants observed a 30% reduction in REM latency and a 20% increase in dream vividness. These **alkaloids**, products of complex **chemical synthesis**, demonstrate **neurotransmitter receptor influence on behavior**, offering new insights into **psychology**. The **intersection** of these **drug studies** and fundamental **sleep** processes reveals therapeutic potential for sleep disorders, a critical area for understanding human consciousness.
Abstract
The interplay between psychedelics, such as psilocybin, lysergic acid diethylamide (LSD) and dimethyltryptamine (DMT), and sleep is an emerging area, but their impact on sleep remains relatively underexplored. This viewpoint provides a perspective on how psychedelics may alter sleep phases, dreaming, and their potential therapeutic applications for sleep disorders.